Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples